新型二氨基嘧啶甲酰胺类化合物作为治疗癌症的HPK1抑制剂
Novel Diaminopyrimidine Carboxamides as HPK1 Inhibitors for Treating Cancer.
作者信息
Sabnis Ram W
机构信息
Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
出版信息
ACS Med Chem Lett. 2023 Jun 21;14(7):899-900. doi: 10.1021/acsmedchemlett.3c00249. eCollection 2023 Jul 13.
Abstract
Provided herein are novel diaminopyrimidine carboxamides as HPK1 inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.
摘要
本文提供了作为HPK1抑制剂的新型二氨基嘧啶羧酰胺、药物组合物、此类化合物在治疗癌症中的用途以及制备此类化合物的方法。
相似文献
1
Novel Diaminopyrimidine Carboxamides as HPK1 Inhibitors for Treating Cancer.新型二氨基嘧啶甲酰胺类化合物作为治疗癌症的HPK1抑制剂
ACS Med Chem Lett. 2023 Jun 21;14(7):899-900. doi: 10.1021/acsmedchemlett.3c00249. eCollection 2023 Jul 13.
2
Novel Tetrahydropyrido[3,4-]pyrimidines as HPK1 Inhibitors for Treating Cancer, Inflammatory, and Autoimmune Diseases.新型四氢吡啶并[3,4-]嘧啶类化合物作为用于治疗癌症、炎症和自身免疫性疾病的HPK1抑制剂
ACS Med Chem Lett. 2024 Jan 31;15(3):318-319. doi: 10.1021/acsmedchemlett.4c00023. eCollection 2024 Mar 14.
3
Novel Pyrido[3,2-]pyrimidines as HPK1 Inhibitors for Treating Cancer and Inflammatory and Autoimmune Diseases.新型吡啶并[3,2-]嘧啶类化合物作为用于治疗癌症、炎症和自身免疫性疾病的HPK1抑制剂
ACS Med Chem Lett. 2023 Nov 27;14(12):1627-1628. doi: 10.1021/acsmedchemlett.3c00506. eCollection 2023 Dec 14.
4
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds.作为临床前免疫治疗工具化合物的二氨基嘧啶甲酰胺HPK1抑制剂的发现。
ACS Med Chem Lett. 2021 Mar 19;12(4):653-661. doi: 10.1021/acsmedchemlett.1c00096. eCollection 2021 Apr 8.
5
Novel 2,4- diaminopyrimidine 5-carboxamides as c-Jun -terminal Kinase Inhibitors for Treating the Liver Fibrotic Disorder.新型 2,4-二氨基嘧啶 5-甲酰胺作为 c-Jun 末端激酶抑制剂用于治疗肝纤维化疾病。
Endocr Metab Immune Disord Drug Targets. 2023;23(8):1118-1123. doi: 10.2174/1871530323666230220123228.
6
Design, synthesis, and biological evaluation of 2,4-diaminopyrimidine derivatives as potent Hematopoietic Progenitor Kinase 1 (HPK1) inhibitors.设计、合成及 2,4-二氨基嘧啶衍生物作为有效造血祖细胞激酶 1（HPK1）抑制剂的生物评价。
Bioorg Chem. 2024 Jul;148:107454. doi: 10.1016/j.bioorg.2024.107454. Epub 2024 May 19.
7
Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1.发现二氨基三嗪甲酰胺类化合物是强效的造血前体细胞激酶 1 抑制剂。
Bioorg Chem. 2023 Sep;138:106682. doi: 10.1016/j.bioorg.2023.106682. Epub 2023 Jun 16.
8
3-Alkynyl Carboxamides as AEP Modulators for Treating Alzheimer's Disease.作为治疗阿尔茨海默病的天冬氨酸内肽酶（AEP）调节剂的3-炔基羧酰胺
ACS Med Chem Lett. 2024 Jan 4;15(2):159-160. doi: 10.1021/acsmedchemlett.3c00544. eCollection 2024 Feb 8.
9
Discovery of 7H-Pyrrolo[2,3-d]pyrimidine Derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors.发现 7H-吡咯并[2,3-d]嘧啶衍生物作为有效的造血祖细胞激酶 1（HPK1）抑制剂。
Eur J Med Chem. 2023 Jun 5;254:115355. doi: 10.1016/j.ejmech.2023.115355. Epub 2023 Apr 10.
10
Development of a series of quinazoline-2,5-diamine derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors.一系列喹唑啉-2,5-二胺衍生物作为有效的造血祖细胞激酶1（HPK1）抑制剂的开发。
Eur J Med Chem. 2023 Feb 15;248:115064. doi: 10.1016/j.ejmech.2022.115064. Epub 2022 Dec 30.
引用本文的文献
1
Novel Pyrido[3,2-]pyrimidines as HPK1 Inhibitors for Treating Cancer and Inflammatory and Autoimmune Diseases.新型吡啶并[3,2-]嘧啶类化合物作为用于治疗癌症、炎症和自身免疫性疾病的HPK1抑制剂
ACS Med Chem Lett. 2023 Nov 27;14(12):1627-1628. doi: 10.1021/acsmedchemlett.3c00506. eCollection 2023 Dec 14.
本文引用的文献
1
Role of protein phosphorylation in cell signaling, disease, and the intervention therapy.蛋白质磷酸化在细胞信号传导、疾病及干预治疗中的作用。
MedComm (2020). 2022 Nov 3;3(4):e175. doi: 10.1002/mco2.175. eCollection 2022 Dec.
2
The development of small-molecule inhibitors targeting HPK1.靶向HPK1的小分子抑制剂的研发
Eur J Med Chem. 2022 Dec 15;244:114819. doi: 10.1016/j.ejmech.2022.114819. Epub 2022 Oct 4.
3
Hematopoietic Progenitor Kinase 1 in Tumor Immunology: A Medicinal Chemistry Perspective.造血祖细胞激酶 1 在肿瘤免疫学中的作用：从药物化学角度看。
J Med Chem. 2022 Jun 23;65(12):8065-8090. doi: 10.1021/acs.jmedchem.2c00172. Epub 2022 Jun 13.
4
Novel Isoindolone Compounds as HPK1 Inhibitors for Treating Cancer.新型异吲哚酮化合物作为用于治疗癌症的HPK1抑制剂
ACS Med Chem Lett. 2022 Jan 12;13(2):156-157. doi: 10.1021/acsmedchemlett.1c00725. eCollection 2022 Feb 10.
Zotero 插件